Study: Breast imaging with contrast agents needs blood flow monitoring

01/23/2014 | HealthImaging.com

A new study suggests that breast imaging protocols that incorporate injected contrast agents should include monitoring of changes in blood flow caused by mammographic compression, as compression significantly reduces contrast and may affect imaging outcomes. Using diffuse optical and diffuse correlation spectroscopies, researchers noted reductions in total hemoglobin content and blood flow under pressure in 15 healthy patients, according to the study published in Academic Radiology.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC